medigraphic.com
Instituto Nacional de Salud Pública

2011, Number 1

<< Back Next >>

salud publica mex 2011; 53 (1)

Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention

Language: Spanish
References: 89
Page: 57-65
PDF size: 239.83 Kb.


ABSTRACT

Pertussis continues to be responsible for a significant disease burden worldwide. Although immunization practices have reduced the occurrence of the disease among children, waning vaccine- and infection-induced immunity still allows the disease to affect adolescents and adults who, in turn, can transmit the disease to non-immunized or partially immunized infants. This document is the result of a meeting in Mexico City of international experts who analyzed recent medical information in order to establish the current status of the epidemiology, diagnosis and surveillance of pertussis and, especially, the value of the dTpa booster dose in adolescents and adults as a pertussis prevention strategy in Mexico.


REFERENCES

  1. Mattoo S, Cherry J. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326.

  2. Versteegh FGA, Schellekens JFP, Fleer A, Roord JJ. Pertussis: a concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in management. Rev Med Microbiol 2005;16:79-89.

  3. World Health Organization. Dept. of Vaccines and Other Biologicals. Pertussis surveillance: a global meeting : Geneva, 16-18 October 2000. Geneva: World Health Organization, Dept. of Vaccines and Biologicals, 2001.

  4. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003;290:2968-2975.

  5. Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-51.

  6. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005;24:761-765.

  7. Halperin SA. The control of pertussis--2007 and beyond. N Engl J Med 2007;356:110-113.

  8. Aguas R, Goncalves G, Gomes MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis 2006;6:112-117.

  9. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005;115:1422-1427.

  10. Brooks DA, Clover R. Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 2006;19:603-611.

  11. Wilder-Smith A, Ng S, Earnest A. Seroepidemiology of pertussis in the adult population of Singapore. Ann Acad Med Singapore 2006;35:780-782.

  12. Hewlett EL, Edwards KM. Clinical practice. Pertussis--not just for kids. N Engl J Med 2005;352:1215-1222.

  13. Cortese MM, Baughman AL, Zhang R, Srivastava PU, Wallace GS. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics 2008;121:484-492.

  14. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis 2006;42:1439-1442.

  15. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-989.

  16. Moraga F, Roca J, Mendez C, Rodrigo C, Pineda V, Martinez A, et al. Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001. Pediatr Infect Dis J 2005;24:510-513.

  17. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26:293-299.

  18. Baptista PN, Magalhã£Es VS, Rodrigues LC. The role of adults in household outbreaks of pertussis. Int J Inf Dis 2009:1-4.

  19. Jenkinson D. Natural course of 500 consecutive cases of whooping cough: a general practice population study. BMJ 1995;310:299-302.

  20. Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995;21:639-642.

  21. Gilberg S, Njamkepo E, Du Chatelet IP, Partouche H, Gueirard P, Ghasarossian C, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. J Infect Dis 2002;186:415-418.

  22. Von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002;2:744-750.

  23. Herwaldt LA. Pertussis in adults. What physicians need to know. Arch Intern Med 1991;151:1510-1512.

  24. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005;24:S25-34.

  25. Patriarca PA, Biellik RJ, Sanden G, Burstyn DG, Mitchell PD, Silverman PR, et al. Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health 1988;78:833-836.

  26. Pertussis outbreak -- Vermont, 1996. MMWR Morb Mortal Wkly Rep 1997;46:822-826.

  27. Ulloa-Gutierrez R, Avila-Aguero M. Pertussis in Latin America: current situation and future vaccination challenges. Expert Rev Vaccines 2008;7:1569-1580.

  28. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999;28 Suppl 2:S112-117.

  29. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984;14:1-78.

  30. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464-471.

  31. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999;28 Suppl 2:S107-111.

  32. Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002;51:73-76.

  33. Forsyth K. Pertussis, Still a Formidable Foe. Clin Infect Dis 2007;45.

  34. Cherry J. The science and fiction of the» resurgence» of pertussis. Pediatrics 2003;112:405.

  35. Groseclose SL, Brathwaite WS, Hall PA, Connor FJ, Sharp P, Anderson WJ, et al. Summary of notifiable diseases--United States, 2002. MMWR Morb Mortal Wkly Rep 2004;51:1-84.

  36. Miller E, Fleming DM, Ashworth LA, Mabbett DA, Vurdien JE, Elliott TS. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health 2000;3:132-134.

  37. Aoyama T, Takeuchi Y, Goto A, Iwai H, Murase Y, Iwata T. Pertussis in adults. Am J Dis Child 1992;146:163-166.

  38. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003;3:413-418.

  39. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005;24:S10-18.

  40. Cherry JD, Beer T, Chartrand SA, DeVille J, Beer E, Olsen MA, et al. Comparison of values of antibody to Bordetella pertussis antigens in young German and American men. Clin Infect Dis 1995;20:1271-1274.

  41. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32:1691-1697.

  42. Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, Mayon-White R, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 2006;333:174-177.

  43. Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 2001;7:526-528.

  44. King AJ, van Gorkom T, van der Heide HG, Advani A, van der Lee S. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genomics 2010;11:64.

  45. Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergard T, Schneerson R, et al. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Pediatrics 2001;108:E115.

  46. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997;16:S85-89.

  47. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005;133:159-171.

  48. Pichichero ME. Booster vaccinations: can immunologic memory outpace disease pathogenesis? Pediatrics 2009;124:1633-1641.

  49. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000;182:1409-1416.

  50. Gutierrez G, Kumate J, Mendia AM. Immunological survey of the infantile population of Mexico, D.F. II. Investigation of antibodies against Hemophilus pertussis. Bol Med Hosp Infant Mex 1965;22:833-836.

  51. Perez Miravete A, Perez de la Mora S. Serological tests to investigate parapertussis infections in Mexico. Rev Invest Salud Publica 1966;26:235-244.

  52. Gutierrez G, Ruiz-Gomez J. Seroepidemiology of 10 infectious diseases in children in Mexico City. Measles, rubella, parotitis, typhoid, whooping cough, amebiasis, influenza and adenovirus infections, Mycoplasma pneumoniae and herpes simplex. Gac Med Mex 1973;105:529-540.

  53. Sapian-Lopez LA, Valdespino JL, Salvatierra B, Tapia-Conyer R, Gutierrez G, Macedo J, et al. Seroepidemiology of whooping cough in Mexico. Salud Publica Mex 1992;34:177-185.

  54. Navarrete-Navarro S, Gonzalez-Romero M, Ruiz-Matus C, Casasola-Flores J. Epidemiologic study of a whooping cough outbreak in Rincon Grande, Veracruz. Bol Med Hosp Infant Mex 1990;47:304-312.

  55. Tomé-Sandoval P, Torres-Arreola LP, Romero-Quechol G, Guiscafré-Gallardo H. Bordetella pertussis in adolescents students in Mexico City. Rev Saúde Pública 2008;42:679-683.

  56. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ 2005;172:509-515.

  57. Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J 2005;24:721-728.

  58. Sintchenko V. The re-emergence of pertussis: implications for diagnosis and surveillance. N S W Public Health Bull 2008;19:143-145.

  59. Eidlitz-Markus T, Mimouni M, Zeharia A. Pertussis symptoms in adolescents and children versus infants: the influence of vaccination and age. Clin Pediatr 2007;46:718-723.

  60. Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest 1999;115:1254-1258.

  61. Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 1987;146:522-525.

  62. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006;31:52-61.

  63. Hitchcock WP. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use. Clin Pediatr 2006;45:785-794.

  64. Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria. Pediatr Infect Dis J 2007;26:806-810.

  65. Ward JI, Cherry JD, Chang S-J, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555-1563.

  66. Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. J Pediatr 2006;149:603-610.

  67. Halperin SA. Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States. Pediatr Infect Dis J 2005;24:S141-146.

  68. Wirsing von Konig CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005;24:S87-92.

  69. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006;55:1-37.

  70. Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics 2006;117:1084-1093.

  71. Zepp F, Habermehl P, Knuf M, Mannhardt-Laakman W, Howe B, Friedland LR. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Vaccine 2007;25:5248-5252.

  72. Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005;293:3003-3011.

  73. Tan T, Halperin S, Cherry JD, Edwards K, Englund JA, Glezen P, et al. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005;24:S83-86.

  74. Forsyth K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005;24:S93-97.

  75. Centro Nacional para la Salud de la Infancia y la Adolescencia (CeNSIA). Lineamientos Generales Vacunación Universal y Semanas Nacionales de Salud 2007. [Accesado 2010 octubre 20]. Disponible en : www.enfermedadesinfecciosas.com/files/vacunacion_universal_ lineamientos.pdf.

  76. America Academy of Pediatrics Commitee on Infectious D. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 2006;117:965-978.

  77. Zepp F, Bernatowska E, Guiso N, Heininger U, Mertsola J, Roord J, et al. Consensus on pertussis booster vaccination in Europe. In: ESPID. Brussels, Belgium; 2009.

  78. Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev 2008;21:426-434.

  79. Mooi F, Degreeff S. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007;7:614-624.

  80. Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1997;99:479-488.

  81. Cortese MM, Baughman AL, Brown K, Srivastava P. A “new age” in pertussis prevention new opportunities through adult vaccination. Am J Prev Med 2007;32:177-185.

  82. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007;25:2634-2642.

  83. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004;22:3154-3165.

  84. Peadon E, Cooper C. Whooping cough: are health-care workers putting children at risk? J Paediatr Child Health 2007;43:398-402.

  85. Calugar A, Ortega-Sanchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006;42:981-988.

  86. Forsyth K, Tan T, von Konig CH, Caro JJ, Plotkin S. Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J 2005;24:S69-74.

  87. Schellekens J, von Konig CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 2005;24:S19-24.

  88. Lichty JA, Slavin B, Bradford WL. An Attempt to Increase Resistance to Pertussis in Newborn Infants by Immunizing Their Mothers during Pregnancy. J Clin Invest 1938;17:613-621.

  89. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001;183:1353-1359.




2020     |     www.medigraphic.com